Oral Activated Charcoal Prevents Experimental Cerebral Malaria in Mice and in a Randomized Controlled Clinical Trial in Man Did Not Interfere with the Pharmacokinetics of Parenteral Artesunate

J. Brian de Souza, Uduak Okomo, Neal D. Alexander et al. · 2010

Read Oral Activated Charcoal Prevents Experimental Cerebral Malaria in Mice and in a Randomized Controlled Clinical Trial in Man Did Not Interfere with the Pharmacokinetics of Parenteral Artesunate by J. Brian de Souza, Uduak Okomo, Neal D. Alexander et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009867.txt.

Description

Cerebral malaria is the deadliest form of malaria, attacking the brain. J. Brian de Souza and colleagues tested whether swallowing activated charcoal could prevent it in mice. Their study appeared in PLOS ONE in 2010.

Activated charcoal soaks up chemicals in the gut and is a standard poison treatment. The mouse results were paired with a randomized controlled trial in people. That trial checked whether charcoal interfered with intravenous artesunate, a key malaria drug. It did not, clearing one safety worry for the idea. The human trial focused on drug levels, not on curing malaria.

Catalog record

CREATORJ. Brian de Souza, Uduak Okomo, Neal D. Alexander et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009867

Browse the full library · About the Tower of Babel